Evidence map›Paper›PMID 42625632›Full record

ArticleFrontiers in oncology2026

Case Report: Complete response and prolonged survival to alectinib in a NSCLC patient with metastases harboring a rare

Lauren Epler, Giovanny Velasquez, Isa Mambetsariev, Javier Arias-Romero, Jeremy Fricke, Neil Chen, Razmig Babikian, Linh Ngo, Leonidas Arvanitis, Amit A Kulkarni and 4 more

Erratum issuedAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Lauren EplerDepartment of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Giovanny VelasquezDepartment of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Isa MambetsarievDepartment of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Javier Arias-RomeroDepartment of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Jeremy FrickeDepartment of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Neil ChenDepartment of Biology, Northwestern University, Chicago, IL, United States.
Razmig BabikianDepartment of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Linh NgoDepartment of Pharmacy, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Leonidas ArvanitisDepartment of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Amit A KulkarniDepartment of Medical Oncology and Therapeutics Research, City of Hope Phoenix, Goodyear, AZ, United States.
Deniz A UrgunDepartment of Diagnostic Radiology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Stephen GruberDepartment of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Michelle AfkhamiDepartment of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Ravi SalgiaDepartment of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
NCI NIH HHS P30 CA033572
6 · The paper itself

Abstract

Anaplastic lymphoma kinase (

Indexed as

ALK structural deletionALK tyrosine kinase inhibitorNSCLCprecision oncologyWDR43::ALK

Identifiers

PMID42625632
PMCPMC13489892

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.